Trevi Therapeutics Stock (NASDAQ: TRVI) stock price, news, charts, stock research, profile.
Open | $3.51 |
Close | $3.44 |
Volume / Avg. | 1.12M / 238.25K |
Day Range | $3.40 - $3.57 |
52 Wk Range | 0.97 - 4.00 |
Market Cap | $249.72M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 61 |
Short Interest | 3.43% |
Days to Cover | 12.93 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Trevi Therapeutics (NASDAQ:TRVI) through any online brokerage.
Other companies in Trevi Therapeutics’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Zevra Therapeutics (NASDAQ:ZVRA), Theravance Biopharma (NASDAQ:TBPH), GH Research (NASDAQ:GHRS) and Xeris Biopharma Holdings (NASDAQ:XERS).
Trevi Therapeutics has a consensus price target of $8.73.
The stock price for Trevi Therapeutics (NASDAQ: TRVI) is $3.44 last updated September 20, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Trevi Therapeutics.
Trevi Therapeutics’s Q3 earnings are confirmed for Thursday, November 7, 2024.
There is no upcoming split for Trevi Therapeutics.
Trevi Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.